Syncona Share News (SYNC)

Syncona Information

Buy SYNC Shares
Add SYNC to Watchlist
Add SYNC to Alert

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 120.40

Bid: 120.00

Ask: 120.40

Change: -1.60 (-1.31%)

Spread: 0.40 (0.333%)

Open: 120.20

High: 121.60

Low: 120.20

Prev. Close: 122.00

Last checked at -

Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Syncona portfolio firm Achilles Therapeutics prices US share offering

Thu, 25th Mar 2021 12:23

(Alliance News) - Syncona Ltd on Thursday said investee Achilles Therapeutics PLC has amended a US regulatory filing in relation to an offering of American depositary shares.

The document sent to the US Securities & Exchange Commission said Achilles ADS shares will be priced between USD17.00 and USD19.00 each. They each represent one ordinary share in the company.

Life sciences-focused investor Synonca said this would represent an increase of its holding in Achilles to between GBP42.9 million and GBP59.1 million.

Syncona shares were flat at 262.50 pence each in London on Thursday.

By Eric Cunha; ericcunha@alliancenews.com

More News

26 Mar 2021 09:20

Syncona invests USD42 million into Gyroscope to have 54% stake

26 Mar 2021 07:59

Syncona invests £31m in Gyroscope

(Sharecast News) - Syncona has invested $42.3m (£31m) in Gyroscope Therapeutics as part of a $148m financing by the retinal gene therapy company.

4 Mar 2021 12:46

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

2 Mar 2021 13:45

IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO

12 Feb 2021 16:24

IN BRIEF: Syncona's Gyroscope Reports Positive Results From GT005 Test

11 Feb 2021 10:05

Syncona Net Asset Value Dips In Third Quarter, Invests More In Quell

11 Feb 2021 07:56

Syncona makes decent progress in December quarter

(Sharecast News) - Healthcare investment company Syncona updated the market on its latest quarter on Thursday, reporting clinical, financial and operational progress across its portfolio in the three months ended 31 December.

10 Feb 2021 09:41

Syncona Investee Autolus Nets USD100 Million From ADS Offer

10 Feb 2021 09:31

Syncona upbeat on Autolus US public offering pricing

(Sharecast News) - Healthcare investor Syncona said on Wednesday that its portfolio company Autolus Therapeutics has priced its underwritten public offering in the United States at $7.00 per American depositary share (ADS).

8 Feb 2021 13:09

Syncona Investee Freeline Modifies Hemophilia Plan After FDA Feedback

5 Feb 2021 08:20

Syncona Investee Achilles Reports Positive Trial Review, Mulling IPO

5 Feb 2021 08:01

Syncona investment Achilles upbeat on safety review of trials

(Sharecast News) - Healthcare investor Syncona said on Friday that its portfolio company Achilles Therapeutics, which is developing precision T-cell therapies to treat solid tumours, had announced that an independent data and safety monitoring committee had completed the first review of the ongoing, first-in-human phase 1 and 2 'CHIRON' and 'THETIS' trials.

6 Jan 2021 09:30

Syncona Investee Autolus To Focus On Adult Leukemia Programme in 2021

6 Jan 2021 08:36

Syncona upbeat on developments at Autolus

(Sharecast News) - Life science investor Syncona updated the market on its portfolio company Autolus on Wednesday, announcing that it would prioritise the development of the 'AUTO1' programme for adult acute lymphoblastic leukemia (ALL), based on the positive data generated in its phase 1 and 2 studies to date and a high unmet medical need.

Latest Share Chat

Syncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Syncona portfolio firm Achilles Therapeutics prices US share offering

Login to your account

Quickpicks are a member only feature

Login to your account